Staidson (Beijing) Biopharmaceuticals Company (SHE: 300204)

Staidson (Beijing) Biopharmaceuticals Company is a corporation based in Beijing, China. Established in 2002, the company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin. The assets are managed by the executive management team.